TP53 and breast cancer: Moreover, in genome-doubled breast cancers, the majority of PIK3CA mutations precede the genome duplication event, with PIK3CA mutations showing a tendency to be mutually exclusive with mutations in TP53 [93], a known tolerance mechanism towards genome doubling [43,44,45].